National Academy of Sciences | 150 Year Anniversary

Questions? Call 800-624-6242

| Items in cart [0]

The National Academies Press

PAPERBACK
price:$59.95
add to cart

Rights & Permissions

topleft topright

Health Risks from Exposure to Low Levels of Ionizing Radiation: BEIR VII Phase 2 (2006)
Board on Radiation Effects Research (BRER)

Citation Manager

. "12 Estimating Cancer Risk." Health Risks from Exposure to Low Levels of Ionizing Radiation: BEIR VII Phase 2. Washington, DC: The National Academies Press, 2006.

Please select a format:

BibTeX EndNote RefMan


Page
312
bottomleft bottomright

The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy.


Health Risks from Exposure to Low Levels of Ionizing Radiation: Beir VII Phase 2

TABLE 12D-3 Lifetime Attributable Risk of Solid Cancer Incidence and Mortalitya

 

Incidence: Exposure Scenario

Mortality: Exposure Scenario

Cancer site

1 mGy per Year throughout Life

10 mGy per Year from Ages 18 to 65

1 mGy per Year throughout Life

10 mGy per Year from Ages 18 to 65

Males

Stomach

24

123

13

66

Colon

107

551

53

273

Liver

18

93

14

72

Lung

96

581

99

492

Prostate

32

164

6.3

32

Bladder

69

358

16

80

Other

194

801

85

395

Thyroid

14

28

 

All solid

554

2699

285

1410

Leukemia

67

360

47

290

All cancers

621

3059

332

1700

Females

Stomach

32

163

19

94

Colon

72

368

34

174

Liver

8.7

44

8

40

Lung

229

1131

204

1002

Breast

223

795

53

193

Uterus

14

19

3.5

18

Ovary

29

140

18

91

Bladder

71

364

21

108

Other

213

861

98

449

Thyroid

75

139

 

All solid

968

4025

459

2169

Leukemia

51

270

38

220

All cancers

1019

4295

497

2389

NOTE: Number of cases or deaths per 100,000 persons exposed to 1 mGy per year throughout life or to 10 mGy per year from ages 18 to 64.

aThese estimates are obtained as combined estimates based on relative and absolute risk transport and have been adjusted by a DDREF of 1.5, except for leukemia, which is based on a linear-quadratic model.

Page
312